AIM Vaccine Co., Ltd. (HKG:6660)

Hong Kong · Delayed Price · Currency is HKD

3.000

+0.150 (5.26%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Sale of Vaccine and Research and Development Services	1.29B	1.19B	1.26B	1.57B	1.64B
Sale of Vaccine and Research and Development Services Growth	8.22%	-6.06%	-19.49%	-4.14%	72.12%
Total	1.29B	1.19B	1.26B	1.57B	1.64B
Total Growth	8.22%	-6.06%	-19.49%	-4.14%	72.12%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Mainland China	1.28B	1.19B	-	-	-
Mainland China Growth	7.64%	-	-	-	-
Other Countries	6.81M	-	-	-	-
People's Republic of China	-	-	1.26B	1.57B	1.64B
People's Republic of China Growth	-	-	-19.49%	-4.14%	72.12%
Total	1.29B	1.19B	1.26B	1.57B	1.64B
Total Growth	8.22%	-6.06%	-19.49%	-4.14%	72.12%

Source: S&P Global Market Intelligence.